Belgium· BE-AMP-SAM660418-00
Yselty 200 mg
A linzagolix product containing linzagolix choline, registered in Belgium by Theramex Ireland. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Linzagolix is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CC04 (linzagolix), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Linzagolix · ATC H01CC04
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of linzagolix costs, country by country.
Normalised to the WHO defined daily dose (0.13 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linzagolix · price per daily dose (0.13 g)
USD · FX 28 Sept 2026
- IT Italy$6.85
- ES Spain$5.81
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Linzagolix Choline
- Manufacturer
- Theramex Ireland
- Country
- Belgium (BE)
- ATC code
- H01CC04
- ATC class
- Linzagolix
- Defined daily dose
- 0.13 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4674891
- be_apb4880050
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Linzagolix in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/187d310c-b19b-458a-baf0-861ced33974f GET /v1/drugs/187d310c-b19b-458a-baf0-861ced33974f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Yselty 200 mg",
"name_fr": "Yselty 200 mg",
"name_nl": "Yselty 200 mg",
"amp_code": "SAM660418-00",
"strengths": [
"200.0000",
"200.0000",
"200.0000",
"200.0000",
"238.8000"
],
"pack_count": 3,
"substances": [
"Linzagolix Choline",
"Linzagolix",
"Lactose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Linzagolix",
"authorisation_numbers": [
"EU/1/21/1606/002",
"EU/1/21/1606/004"
]
}See everything about linzagolix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.